z-logo
Premium
Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat
Author(s) -
Cristol JeanPaul,
Warner Timothy D.,
Thiemermann Christoph,
Vane John R.
Publication year - 1993
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1993.tb12877.x
Subject(s) - endothelins , endothelin receptor , vasoconstriction , renal circulation , medicine , endocrinology , vasoconstrictor agents , receptor , kidney , renal blood flow , endothelin 1 , blood pressure , receptor antagonist , antagonist , chemistry , pharmacology
1 Using endothelin‐1 (ET‐1), endothelin‐3 (ET‐3), sarafotoxin 6b (SX6b) and sarafotoxin 6c (SX6c) as agonists and BQ‐123 as a selective ET A receptor antagonist, we have examined the endothelin receptor subtypes mediating the systemic pressor and renal vasoconstrictor effects of the ET/SX family of peptides. 2 In anaesthetized rats, bolus intravenous injections of ET‐1, ET‐3, SX6b or SX6c (0.1, 0.25 and 0.50 nmol kg −1 ) produced initial transient depressor responses followed by sustained and dose‐dependent increases in mean arterial pressure (MAP) with the following rank order of potency: SX6b>ET‐1 ≫SX6c>ET‐3. In contrast, in the renal vasculature these peptides caused equipotent dose‐dependent falls in renal blood flow (RBF) (ET‐1 = ET‐3 = SX6b = SX6c). 3 BQ‐123 (1 mg kg −1 , i.v. bolus) significantly reduced the systemic pressor effects of all the peptides but was largely ineffective against the renal vasoconstrictions. 4 These results indicate that although the systemic pressor effects of the ET/SX peptides are mediated via ET A receptors, the vasoconstriction in the kidney in vivo may be mediated predominantly via ET B ‐like receptors. This may be of therapeutic relevance, for an ET A ‐receptor‐selective antagonist could offer only poor protection of the renal circulation from the deleterious effects of endogenously produced members of this peptide family.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here